BioNTech SE (22UA.F) FSX

80.50

+1.35(+1.71%)

Updated at December 23 06:46PM

Currency In EUR

Valuation

Market Cap26.13B
Enterprise Value16.62B
P/E Ratio-55.98
PEG Ratio-1
Price/Sales Ratio6.72
Price/Book Ratio1.05
Enterprise/Revenue3.25
Enterprise/EBITDA-41.11

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.12
Operating Margin-0.3

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.02

Income Statement

Revenue2.75B
Revenue/Share11.91
Gross Profit2.21B
EBITDA-367.1M
Net Income-665.3M
Diluted EPS-2.77

Balance Sheet

Total Cash14.53B
Total Cash/Share58.09
Total Debt245.4M
Total Debt/Equity0.01
Current Ratio8.61
Book Value Per Share76.59

Price History

52-Week Change-26.82
52-Week High124.6
52-Week Low71
Moving Average 50 Days86.83
Moving Average 200 Days89.4

Statistics

Average Volume1,490
Shares Outstanding240.46M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A